Edit Content
Bizwit-Logo-Final

Bizwit Research & Consulting LLP is a global provider of business intelligence & consulting services. We have a strong primary base of key industry leaders along with the chain of industry analysts to analyze the market trends and its future impact in order to estimates and forecast different business segments and markets. 

Global Cellular ImmunotherapyMarket to reach xx by 2028.

Global Cellular Immunotherapy Market Size study, byTherapy Type (CAR T Cell Therapy, Dendritic Cell Therapy, NK Cell Therapy, TIL Therapy, Others), By Indication (B-cell Malignancies, Prostate Cancer, Liver Cancer, Renal Cell Carcinoma, Others), By End-use (Hospitals, Cancer Institutes,Others) and Regional Forecasts 2022-2028

Product Code: HLSDT-83545988
Publish Date: 4-07-2022
Page: 200

Global Cellular Immunotherapy Market is valued at approximately XX in 2021 and is anticipated to grow with a healthy growth rate of more than xx% over the forecast period 2022-2028. Cellular immunotherapy, also known as adoptive cell therapy, is a type of cancer treatment that employs immune system cells.The development of advanced cell-based therapies, the rising prevalence of cancer, and increased R&D investment by key companies are some of the major factors driving market growth. Furthermore, the increasing number of product approvals and growing adoption of these therapies for cancer treatment is driving market growth.According to Globocan estimates, an estimated 19.2 million new cancer cases were reported worldwide in 2020, with this figure expected to rise to 24.5 million by 2030. Cancer is expected to kill 10 million people by 2020. According to Cancer Research UK, over 375,000 new cancer cases are reported in the United Kingdom each year. Furthermore, according to WHO estimates, two-thirds of the world’s population aged 60 and up lives in developing countries. The most common factor that increases the risk of cancer is ageing. As a result, the rising geriatric population is expected to increase in prevalence over the forecast period, driving demand for cellular immunotherapies.However, the high cost of manufacturing cellular immunotherapy products is expected to limit growth.

The key regions considered for the global Cellular Immunotherapy marketstudy includeAsia Pacific, North America, Europe, Latin America, and Rest of the World.The Asia Pacific region is predicted to grow at the fastest rate due to unexplored prospects and increased awareness about cellular immunotherapy, as well as quickly building healthcare infrastructure. Because of its well-established healthcare infrastructure, availability of advanced therapies, high disposable income, and high per capita healthcare expenditure, North America dominated the market in terms of revenue in 2021.

Major market players included in this report are:
Bristol-Myers Squibb Company
Novartis AG
Gilead Sciences Inc. (Kite Pharma)
F. Hoffmann-La Roche Ltd
Merck KGaA
GlaxoSmithKline plc.
AstraZeneca
Pfizer Inc.
Johnson & Johnson
Celyad
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
ByTherapy Type:
CAR T Cell Therapy
Dendritic Cell Therapy
NK Cell Therapy
TIL Therapy
Others

ByIndication:
B-cell Malignancies
Prostate Cancer
Liver Cancer
Renal Cell Carcinoma
Others
ByEnd-use:
Hospitals
Cancer Institutes
Others

By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE

Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World

Furthermore, years considered for the study are as follows:

Historical year – 2018, 2019, 2020
Base year – 2021
Forecast period – 2022 to 2028

Target Audience of the Global Cellular Immunotherapy Market in Market Study:

Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors

Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2020-2028 (USD Million)
1.2.1. Cellular Immunotherapy Market, by Region, 2020-2028 (USD Million)
1.2.2. Cellular Immunotherapy Market, by Therapy Type,2020-2028 (USD Million)
1.2.3. Cellular Immunotherapy Market, by Indication, 2020-2028 (USD Million)
1.2.4. Cellular Immunotherapy Market, by End-use, 2020-2028 (USD Million)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Cellular Immunotherapy Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Cellular Immunotherapy Market Dynamics
3.1. Cellular Immunotherapy Market Impact Analysis (2020-2028)
3.1.1. Market Drivers
3.1.1.1. Rising Prevalence of Cancer
3.1.1.2. Technological Advancement in Developing Target-Based Anti-cancer Therapies
3.1.2. Market Challenges
3.1.2.1. The high cost of cellular immunotherapies
3.1.3. Market Opportunities
3.1.3.1. Increasing research and successful clinical trials in cellular immunotherapy
Chapter 4. Global Cellular Immunotherapy Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model (2018-2028)
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
4.5. Top investment opportunity
4.6. Top winning strategies
Chapter 5. Risk Assessment: COVID-19 Impact
5.1.1. Assessment of the overall impact of COVID-19 on the industry
5.1.2. Pre COVID-19 and post COVID-19 market scenario
Chapter 6. Global Cellular Immunotherapy Market, by Therapy Type
6.1. Market Snapshot
6.2. Global Cellular Immunotherapy Market by Therapy Type, Performance – Potential Analysis
6.3. Global Cellular Immunotherapy Market Estimates & Forecasts by Therapy Type, 2018-2028 (USD Million)
6.4. Cellular Immunotherapy Market, Sub Segment Analysis
6.4.1. CAR T Cell Therapy
6.4.2. Dendritic Cell Therapy
6.4.3. NK Cell Therapy
6.4.4. TIL Therapy
6.4.5. Others
Chapter 7. Global Cellular Immunotherapy Market, by Indication
7.1. Market Snapshot
7.2. Global Cellular Immunotherapy Market by Indication, Performance – Potential Analysis
7.3. Global Cellular Immunotherapy Market Estimates & Forecasts by Indication, 2018-2028 (USD Million)
7.4. Cellular Immunotherapy Market, Sub Segment Analysis
7.4.1. B-cell Malignancies
7.4.2. Prostate Cancer
7.4.3. Liver Cancer
7.4.4. Renal Cell Carcinoma
7.4.5. Others
Chapter 8. Global Cellular Immunotherapy Market, by End-use
8.1. Market Snapshot
8.2. Global Cellular Immunotherapy Market by End-use, Performance – Potential Analysis
8.3. Global Cellular Immunotherapy Market Estimates & Forecasts by End-use, 2018-2028 (USD Million)
8.4. Cellular Immunotherapy Market, Sub Segment Analysis
8.4.1. Hospitals
8.4.2. Cancer Institutes
8.4.3. Others
Chapter 9. Global Cellular Immunotherapy Market, Regional Analysis
9.1. Cellular Immunotherapy Market, Regional Market Snapshot
9.2. North America Cellular Immunotherapy Market
9.2.1. U.S. Cellular Immunotherapy Market
9.2.1.1. Therapy Type breakdown estimates & forecasts, 2018-2028
9.2.1.2. Indication breakdown estimates & forecasts, 2018-2028
9.2.1.3. End-use breakdown estimates & forecasts, 2018-2028
9.2.2. Canada Cellular Immunotherapy Market
9.3. Europe Cellular Immunotherapy Market Snapshot
9.3.1. U.K. Cellular Immunotherapy Market
9.3.2. Germany Cellular Immunotherapy Market
9.3.3. France Cellular Immunotherapy Market
9.3.4. Spain Cellular Immunotherapy Market
9.3.5. Italy Cellular Immunotherapy Market
9.3.6. Rest of Europe Cellular Immunotherapy Market
9.4. Asia-Pacific Cellular Immunotherapy Market Snapshot
9.4.1. China Cellular Immunotherapy Market
9.4.2. India Cellular Immunotherapy Market
9.4.3. Japan Cellular Immunotherapy Market
9.4.4. Australia Cellular Immunotherapy Market
9.4.5. South Korea Cellular Immunotherapy Market
9.4.6. Rest of Asia Pacific Cellular Immunotherapy Market
9.5. Latin America Cellular Immunotherapy Market Snapshot
9.5.1. Brazil Cellular Immunotherapy Market
9.5.2. Mexico Cellular Immunotherapy Market
9.6. Rest of The World Cellular Immunotherapy Market

Chapter 10. Competitive Intelligence
10.1. Top Market Strategies
10.2. Company Profiles
10.2.1. Bristol-Myers Squibb Company
10.2.1.1. Key Information
10.2.1.2. Overview
10.2.1.3. Financial (Subject to Data Availability)
10.2.1.4. Indication Summary
10.2.1.5. Recent Developments
10.2.2. Novartis AG
10.2.3. Gilead Sciences Inc. (Kite Pharma)
10.2.4. F. Hoffmann-La Roche Ltd
10.2.5. Merck KGaA
10.2.6. GlaxoSmithKline plc.
10.2.7. AstraZeneca
10.2.8. Pfizer Inc.
10.2.9. Johnson & Johnson
10.2.10. Celyad
Chapter 11. Research Process
11.1. Research Process
11.1.1. Data Mining
11.1.2. Analysis
11.1.3. Market Estimation
11.1.4. Validation
11.1.5. Publishing
11.2. Research Attributes
11.3. Research Assumption

At Bizwit Research and Consultancy, we employ a thorough and iterative research methodology with the goal of minimizing discrepancies, ensuring the provision of highly accurate estimates and predictions over the forecast period. Our approach involves a combination of bottom-up and top-down strategies to effectively segment and estimate quantitative aspects of the market, utilizing our proprietary data & AI tools. Our Proprietary Tools allow us for the creation of customized models specific to the research objectives. This enables us to develop tailored statistical models and forecasting algorithms to estimate market trends, future growth, or consumer behavior. The customization enhances the accuracy and relevance of the research findings.
We are dedicated to clearly communicating the purpose and objectives of each research project in the final deliverables. Our process begins by identifying the specific problem or challenge our client wishes to address, and from there, we establish precise research questions that need to be answered. To gain a comprehensive understanding of the subject matter and identify the most relevant trends and best practices, we conduct an extensive review of existing literature, industry reports, case studies, and pertinent academic research.
Critical elements of methodology employed for all our studies include:
Data Collection:
To determine the appropriate methods of data collection based on the research objectives, we consider both primary and secondary sources. Primary data collection involves gathering information directly from various industry experts in core and related fields, original equipment manufacturers (OEMs), vendors, suppliers, technology developers, alliances, and organizations. These sources encompass all segments of the value chain within the specific industry. Through in-depth interviews, we engage with key industry participants, subject-matter experts, C-level executives of major market players, industry consultants, and other relevant experts. This allows us to obtain and validate critical qualitative and quantitative information while evaluating market prospects. AI and Big Data are instrumental in our primary research, providing us with powerful tools to collect, analyze, and derive insights from data efficiently. These technologies contribute to the advancement of research methodologies, enabling us to make data-driven decisions and uncover valuable findings.
In addition to primary sources, we extensively utilize secondary sources to enhance our research. These include directories, databases, journals focusing on related industries, company newsletters, and information portals such as Bloomberg, D&B Hoovers, and Factiva. These secondary sources enable us to identify and gather valuable information for our comprehensive, technical, market-oriented, and commercial study of the market. Additionally, we utilize AI algorithms to automate the collection of vast amounts of data from various sources such as surveys, social media platforms, online transactions, and web scraping. And employ Big Data technologies for storage and processing of large datasets, ensuring that no valuable information is missed during the data collection process.
Data Analysis:
Our team of experts carefully examine the gathered data using suitable statistical techniques and qualitative analysis methods. For quantitative analysis, we employ descriptive statistics, regression analysis, and other advanced statistical methods, depending on the characteristics of the data. This analysis may also incorporate the utilization of AI tools and big data analysis techniques to extract meaningful insights.
To ensure the accuracy and reliability of our findings, we extensively leverage data science techniques, which help us minimize discrepancies and uncertainties in our analysis. We employ Data Science to clean and preprocess the data, ensuring its quality and reliability. This involves handling missing data, removing outliers, standardizing variables, and transforming data into suitable formats for analysis. The application of data science techniques enhances our accuracy, efficiency, and depth of analysis, enabling us to stay competitive in dynamic market environments.
Market Size Estimation:
Our proprietary data tools play a crucial role in deriving our market estimates and forecasts. Each study involves the creation of a unique and customized model. The model incorporates the gathered information on market dynamics, technology landscape, application development, and pricing trends. AI techniques, such as machine learning and deep learning, aid us to analyze patterns within the data to identify correlations, trends, and relationships. By recognizing patterns in consumer behavior, purchasing habits, or market dynamics, our AI algorithms aid us in more precise estimations of market size. These factors are simultaneously analyzed within the model, allowing for a comprehensive assessment. To quantify their impact over the forecast period, correlation, regression, and time series analysis are employed.
To estimate and validate the market size, we employ both top-down and bottom-up approaches. The preference is given to a bottom-up approach, where key regional markets are analyzed as separate entities. This data is then integrated to obtain global estimates. This approach is crucial as it provides a deep understanding of the industry and helps minimize errors.
In our forecasting process, we consider various parameters such as economic tools, technological analysis, industry experience, and domain expertise. By taking all these factors into account, we strive to produce accurate and reliable market forecasts. When forecasting, we take into consideration several parameters, which include:
Market driving trends and favorable economic conditions
Restraints and challenges that are expected to be encountered during the forecast period.
Anticipated opportunities for growth and development
Technological advancements and projected developments in the market
Consumer spending trends and dynamics
Shifts in consumer preferences and behaviors.
The current state of raw materials and trends in supply versus pricing
Regulatory landscape and expected changes or developments.
The existing capacity in the market and any expected additions or expansions up to the end of the forecast period.
To assess the market impact of these parameters, we assign weights to each one and utilize weighted average analysis. This process allows us to quantify their influence on the market and derive an expected growth rate for the forecasted period. By considering these various factors and applying a weighted analysis approach, we strive to provide accurate and reliable market forecasts.
Insight Generation & Report Presentation:
After conducting the research, our experts analyze the findings in relation to the research objectives and the specific needs of the client. They generate valuable insights and recommendations that directly address the client’s business challenges. These insights are carefully connected to the research findings to provide a comprehensive understanding.
Next, we create a well-structured research report that effectively communicates the research findings, insights, and recommendations to the client. To enhance clarity and comprehension, we utilize visual aids such as charts, graphs, and tables. These visual elements are employed to present the data in an engaging and easily understandable format, ensuring that the information is accessible and visually appealing to the client. Our aim is to deliver a clear and concise report that conveys the research findings effectively and provides actionable recommendations to meet the client’s specific needs.

Need Assistance

Contact Person -
Krishant Mennon
Call us @
+ 91 99931 15879
Email: sales@bizwitresearch.com

Checkout

Why Choose Us?

Quality over Quantity

Backed by 60+ paid data sources our reports deliver crisp insights with no compromise quality.

Analyst Support

24x7 Chat Support plus
free analyst hours with every purchase

Flawless Methodology

Our 360-degree approach of market study, our research methods leave stones unturned.

Enquiry Now